Ascendis Pharma A/S(ASND)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ASND Ascendis Pharma A/S

休市中 07-24 16:00:00 EDT

253.86

+1.20

+0.47%

盘后253.86

+0.000.00%

19:34 EDT

最高258.86	最低251.99	成交量39.04万
今开254.40	昨收252.66	日振幅2.72%
总市值166.51亿	流通市值162.05亿	总股本6,559万
成交额9,961万	换手率0.61%	流通股本6,384万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ASND","market":"US","secType":"STK","nameCN":"Ascendis Pharma A/S","latestPrice":253.86,"timestamp":1784923200000,"preClose":252.66,"halted":0,"volume":390365,"hourTrading":{"tag":"盘后","latestPrice":253.86,"preClose":253.86,"latestTime":"19:34 EDT","volume":30253,"amount":7680031.53,"timestamp":1784936046111,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.004749465685110492,"floatShares":63835655,"shares":65592800,"eps":8.646,"marketStatus":"休市中","change":1.2,"latestTime":"07-24 16:00:00 EDT","open":254.4,"high":258.855,"low":251.99,"amount":99607094.86,"amplitude":0.027171,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":8.646,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1785139200000},"marketStatusCode":7,"adr":1,"adrRate":1,"listingDate":1422421200000,"exchange":"NASDAQ","adjPreClose":252.66,"preHourTrading":{"tag":"盘前","latestPrice":259.99,"preClose":252.66,"latestTime":"09:27 EDT","volume":215,"amount":54920.56105,"timestamp":1784899670044,"change":7.33,"changeRate":0.029011,"amplitude":0.03946},"postHourTrading":{"tag":"盘后","latestPrice":253.86,"preClose":253.86,"latestTime":"19:34 EDT","volume":30253,"amount":7680031.53,"timestamp":1784936046111,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.795580301802056,"impliedVol":0.4946,"impliedVolPercentile":0.6295},"requestUrl":"/m/hq/s/ASND","defaultTab":"news","newsList":[{"id":"1187464751","title":"异动解读｜Ascendis Pharma盘中上涨8.3%，核心药物长期临床数据亮眼叠加分析师看好","url":"https://stock-news.laohu8.com/highlight/detail?id=1187464751","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187464751?lang=zh_cn&edition=full","pubTime":"2026-06-26 00:16","pubTimestamp":1782404163,"startTime":"0","endTime":"0","summary":"6月25日，Ascendis Pharma盘中上涨8.3%，报259.16美元/股，成交额3.27亿美元。消息面上，公司近期公布了核心产品Yorvipath治疗甲状旁腺功能减退症的多项长期数据，市场持续消化利好。三期PaTHway研究3.5年数据显示综合应答率达86%，89%患者完成试验；二期PaTH Forward研究5年数据显示应答率82%，肾功能持续改善。Wedbush发布研报称Yorvipath相较竞品保持显著优势，维持跑赢大市评级及273美元目标价。此外，竞争对手MBX Biosciences同适应症药物二期应答率仅57%，进一步凸显Yorvipath的领先地位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169083837","title":"MBX核心药物试验结果符合预期，但部分投资者或期待更高——市场观察","url":"https://stock-news.laohu8.com/highlight/detail?id=1169083837","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1169083837?lang=zh_cn&edition=full","pubTime":"2026-06-13 01:22","pubTimestamp":1781284950,"startTime":"0","endTime":"0","summary":"MBX Biosciences公布了其用于治疗甲状旁腺功能减退症的药物canvuparatide的二期试验结果，随后股价下跌5.5%。瑞穗银行的分析指出，该药物在52周时达到了57%的综合应答率，这是衡量治疗成功的关键指标，与其竞争对手Yorvipath的64%水平相当。然而，分析人士认为，部分投资者可能会提出异议，因为在与患者使用相关的更宽松标准下，Yorvipath的实际基准应答率可能高达80%。尽管如此，分析师们对此次试验结果以及canvuparatide每周一次的给药方案仍持乐观态度。该方案可将注射次数减少86%，他们表示，这“继续支持canvuparatide的商业潜力”。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4139","BK4211","MBX","BK4585","ISBC","LU0320765992.SGD","LU0889565916.HKD","ASND","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518208844","title":"Ascendis Pharma A/S盘中异动 急速下跌5.16%报138.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518208844","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518208844?lang=zh_cn&edition=full","pubTime":"2025-03-11 00:43","pubTimestamp":1741624985,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日00时43分，Ascendis Pharma A/S股票出现异动，股价快速下挫5.16%。截至发稿，该股报138.22美元/股，成交量11.4887万股，换手率0.19%，振幅3.85%。Ascendis Pharma A/S股票所在的生物技术行业中，整体涨幅为0.67%。Ascendis Pharma A/S公司简介：Ascendis Pharma AS是一家生物制药公司，应用其TransCon技术平台为患者带来有意义的改变。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311004306abf34219&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311004306abf34219&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","ASND","BK4139","LU0889565916.HKD","LU0320765992.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514097967","title":"坎托菲茨杰拉德公司：维持Ascendis Pharma(ASND.US)评级，由增持调整至增持评级, 目标价由170.00美元调整至200.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514097967","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514097967?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:22","pubTimestamp":1740493354,"startTime":"0","endTime":"0","summary":"坎托菲茨杰拉德公司：维持Ascendis Pharma(ASND.US)评级，由增持调整至增持评级, 目标价由170.00美元调整至200.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/25222248383563.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ASND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512611921","title":"Ascendis Pharma A/S盘中异动 早盘股价大涨5.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512611921","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512611921?lang=zh_cn&edition=full","pubTime":"2025-02-18 23:31","pubTimestamp":1739892667,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日23时31分，Ascendis Pharma A/S股票出现异动，股价急速拉升5.50%。截至发稿，该股报152.00美元/股，成交量16.6641万股，换手率0.28%，振幅4.35%。Ascendis Pharma A/S股票所在的生物技术行业中，整体涨幅为0.59%。Ascendis Pharma A/S公司简介：Ascendis Pharma AS是一家生物制药公司。该公司的产品线包括 Transcon 生长激素、Transconpeptides、Transcon PTH、Transcon CNP 等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218233107abd3bcfd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218233107abd3bcfd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","BK4585","ASND","LU0889565916.HKD","BK4139","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511704046","title":"Ascendis Pharma A/S2024财年实现净利润-4.09亿美元，同比增加21.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511704046","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511704046?lang=zh_cn&edition=full","pubTime":"2025-02-16 00:01","pubTimestamp":1739635295,"startTime":"0","endTime":"0","summary":"2月16日，Ascendis Pharma A/S公布财报，公告显示公司2024财年净利润为-4.09亿美元，同比增加21.35%；其中营业收入为3.93亿美元，同比增加36.46%，每股基本收益为-7.06美元。从资产负债表来看，Ascendis Pharma A/S总负债13.31亿美元，其中短期债务5.09亿美元，资产负债比为0.92，流动比率为1.17。机构评级：截至2025年2月16日，当前有16家机构对Ascendis Pharma A/S目标价做出预测，其中目标均价为201.57美元，其中最低目标价为162.69美元，最高目标价为290.23美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250216000204abd030f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250216000204abd030f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ASND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511957350","title":"高盛：维持Ascendis Pharma(ASND.US)评级，由买入调整至买入评级, 目标价由200.00美元调整至225.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2511957350","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511957350?lang=zh_cn&edition=full","pubTime":"2025-02-14 01:38","pubTimestamp":1739468289,"startTime":"0","endTime":"0","summary":"高盛：维持Ascendis Pharma(ASND.US)评级，由买入调整至买入评级, 目标价由200.00美元调整至225.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/14013848150593.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ASND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511525165","title":"Ascendis Pharma A/S盘中异动 大幅拉升12.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511525165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511525165?lang=zh_cn&edition=full","pubTime":"2025-02-13 22:31","pubTimestamp":1739457116,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日22时31分，Ascendis Pharma A/S股票出现异动，股价快速上涨12.79%。截至发稿，该股报142.27美元/股，成交量12.7929万股，换手率0.21%，振幅3.97%。Ascendis Pharma A/S股票所在的生物技术行业中，整体跌幅为0.01%。Ascendis Pharma A/S公司简介：Ascendis Pharma AS是一家生物制药公司。该公司的产品线包括 Transcon 生长激素、Transconpeptides、Transcon PTH、Transcon CNP 等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223156abcdb23a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213223156abcdb23a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","LU0889565916.HKD","ASND","LU0320765992.SGD","BK4139","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168353386","title":"异动解读 | Ascendis Pharma A/S股价盘后大涨6.03%,业绩超预期是推手","url":"https://stock-news.laohu8.com/highlight/detail?id=1168353386","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168353386?lang=zh_cn&edition=full","pubTime":"2025-02-13 05:38","pubTimestamp":1739396317,"startTime":"0","endTime":"0","summary":"Ascendis Pharma A/S在今日盘后交易中股价大涨6.03%,引发市场广泛关注。这家生物科技公司业绩向好的因素推动了股价的上涨。\n\n值得一提的是,Ascendis Pharma在2024年第四季度交出了亮眼的成绩。数据显示,该公司2024年第四季度GAAP每股收益为€-0.64,远好于分析师预期的€-1.07;销售额为€1.73916亿,也高于预期的€1.11178亿。\n\n这一超预期的业绩表现极大增强了投资者对Ascendis Pharma未来发展的信心,市场普遍看好该公司的增长前景。这成为推动公司股价在盘后大涨6.03%的主要原因。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ASND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116279296","title":"异动解读 | Ascendis Pharma A/S去年第四季度业绩超预期,股价盘中大涨5.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=1116279296","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116279296?lang=zh_cn&edition=full","pubTime":"2025-02-13 05:08","pubTimestamp":1739394510,"startTime":"0","endTime":"0","summary":"Ascendis Pharma A/S今日盘中股价大涨5.87%,引发市场关注。\n\n这家生物科技公司在2024年第四季度实现了亮眼的业绩表现。数据显示,Ascendis Pharma 2024年第四季度GAAP每股收益为€-0.64,远好于分析师预期的€-1.07;销售额为€1.73916亿,也高于预期的€1.11178亿。\n\nAscendis Pharma超预期的业绩给市场带来信心,投资者对公司未来增长前景更加乐观,推动了股价在今日盘中大幅上扬。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ASND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140271421","title":"Ascendis Pharma 2024年第四季度GAAP每股收益€-0.64好于预期值€-1.07，销售额€1.73916亿好于预期值€1.11178亿","url":"https://stock-news.laohu8.com/highlight/detail?id=1140271421","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140271421?lang=zh_cn&edition=full","pubTime":"2025-02-13 05:06","pubTimestamp":1739394386,"startTime":"0","endTime":"0","summary":"Ascendis Pharma 2024年第四季度GAAP每股收益€-0.64好于预期值€-1.07，销售额€1.73916亿好于预期值€1.11178亿以上内容来自Benzinga Earnings专栏，原文如下：Ascendis Pharma Q4 2024 GAAP EPS €(0.64) Beats €(1.07) Estimate, Sales €173.916M Beat €111.178M Estimate","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Ascendis Pharma 2024年第四季度GAAP每股收益€-0.64好于预期值€-1.07，销售额€1.73916亿好于预期值€1.11178亿","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509916231","title":"Ascendis Pharma A/S盘中异动 股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509916231","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509916231?lang=zh_cn&edition=full","pubTime":"2025-02-06 01:18","pubTimestamp":1738775901,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日01时18分，Ascendis Pharma A/S股票出现异动，股价大幅上涨5.01%。截至发稿，该股报128.37美元/股，成交量17.1418万股，换手率0.29%，振幅6.36%。Ascendis Pharma A/S股票所在的生物技术行业中，整体涨幅为1.98%。Ascendis Pharma A/S公司简介：Ascendis Pharma AS是一家生物制药公司。该公司的产品线包括 Transcon 生长激素、Transconpeptides、Transcon PTH、Transcon CNP 等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206011821987b9732&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206011821987b9732&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0109394709.USD","ASND","LU0889565916.HKD","LU0320765992.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2507338976","title":"小摩：维持Ascendis Pharma(ASND.US)评级，由增持调整至增持评级, 目标价由165.00美元调整至167.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2507338976","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507338976?lang=zh_cn&edition=full","pubTime":"2025-01-29 21:12","pubTimestamp":1738156357,"startTime":"0","endTime":"0","summary":"小摩：维持Ascendis Pharma(ASND.US)评级，由增持调整至增持评级, 目标价由165.00美元调整至167.00美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/29211247898147.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ASND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505501724","title":"Ascendis Pharma A/S盘中异动 早盘股价大跌5.01%报124.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505501724","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505501724?lang=zh_cn&edition=full","pubTime":"2025-01-22 23:09","pubTimestamp":1737558553,"startTime":"0","endTime":"0","summary":"北京时间2025年01月22日23时09分，Ascendis Pharma A/S股票出现异动，股价急速下挫5.01%。截至发稿，该股报124.49美元/股，成交量3.9009万股，换手率0.07%，振幅5.05%。Ascendis Pharma A/S股票所在的生物技术行业中，整体涨幅为0.69%。其相关个股中，Nutriband Inc.、Nutriband Inc C/Wts 、Immunoprecise Antibodies Ltd.涨幅较大，Immunoprecise Antibodies Ltd.、Hepion Pharmaceuticals, Inc.、Cardio Diagnostics Holdings Inc.较为活跃，换手率分别为739.75%、140.60%、63.55%，振幅较大的相关个股有Immunoprecise Antibodies Ltd.、Immatics N V C/Wts 01/07/2025 、Nutriband Inc C/Wts ，振幅分别为47.48%、41.27%、38.76%。Ascendis Pharma A/S公司简介：Ascendis Pharma AS是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122230913a22bba65&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250122230913a22bba65&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LU0109394709.USD","LU0320765992.SGD","ASND","LU0889565916.HKD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503991925","title":"Ascendis Pharma A/S盘中异动 早盘股价大跌5.00%报128.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503991925","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503991925?lang=zh_cn&edition=full","pubTime":"2025-01-16 23:34","pubTimestamp":1737041690,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日23时34分，Ascendis Pharma A/S股票出现波动，股价大幅下跌5.00%。截至发稿，该股报128.12美元/股，成交量8.0446万股，换手率0.13%，振幅4.62%。Ascendis Pharma A/S股票所在的生物技术行业中，整体跌幅为0.88%。Ascendis Pharma A/S公司简介：Ascendis Pharma AS是一家生物制药公司。该公司的产品线包括 Transcon 生长激素、Transconpeptides、Transcon PTH、Transcon CNP 等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116233450abad5eeb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250116233450abad5eeb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ASND","LU0889565916.HKD","BK4139","LU0109394709.USD","BK4585","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503580829","title":"Ascendis Pharma A/S盘中异动 临近午盘股价大涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2503580829","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503580829?lang=zh_cn&edition=full","pubTime":"2025-01-14 00:37","pubTimestamp":1736786275,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日00时37分，Ascendis Pharma A/S股票出现异动，股价急速拉升5.26%。截至发稿，该股报135.98美元/股，成交量25.3116万股，换手率0.42%，振幅6.11%。Ascendis Pharma A/S股票所在的生物技术行业中，整体跌幅为0.43%。其相关个股中，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.涨幅较大，Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.较为活跃，换手率分别为11917.74%、6611.43%、471.81%，振幅较大的相关个股有Phio Pharmaceuticals Corp.、Salarius Pharmaceuticals, Inc.、Kairos Pharma, Ltd.，振幅分别为336.09%、216.61%、185.36%。Ascendis Pharma A/S公司简介：Ascendis Pharma AS是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011400375596026879&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011400375596026879&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0109394709.USD","BK4585","LU0320765992.SGD","LU0889565916.HKD","BK4139","ASND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2502755815","title":"Ascendis Pharma A/S盘中异动 快速跳水5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502755815","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502755815?lang=zh_cn&edition=full","pubTime":"2025-01-11 03:06","pubTimestamp":1736535983,"startTime":"0","endTime":"0","summary":"北京时间2025年01月11日03时06分，Ascendis Pharma A/S股票出现异动，股价急速下挫5.16%。截至发稿，该股报127.49美元/股，成交量19.68万股，换手率0.33%，振幅5.71%。Ascendis Pharma A/S股票所在的生物技术行业中，整体跌幅为2.11%。Ascendis Pharma A/S公司简介：Ascendis Pharma AS是一家生物制药公司。该公司的产品线包括 Transcon 生长激素、Transconpeptides、Transcon PTH、Transcon CNP 等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011103062395ffa0ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011103062395ffa0ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0889565916.HKD","BK4139","BK4585","LU0109394709.USD","ASND","LU0320765992.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501620565","title":"Ascendis Pharma(ASND.US)获瑞银首次覆盖，给予买入评级, 目标价196.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2501620565","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501620565?lang=zh_cn&edition=full","pubTime":"2025-01-07 20:55","pubTimestamp":1736254509,"startTime":"0","endTime":"0","summary":"Ascendis Pharma(ASND.US)获瑞银首次覆盖，给予买入评级, 目标价196.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/07205547230803.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ASND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492614215","title":"Ascendis Pharma A/S盘中异动 大幅拉升5.07%报136.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492614215","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492614215?lang=zh_cn&edition=full","pubTime":"2024-12-17 00:49","pubTimestamp":1734367771,"startTime":"0","endTime":"0","summary":"北京时间2024年12月17日00时49分，Ascendis Pharma A/S股票出现异动，股价快速拉升5.07%。截至发稿，该股报136.45美元/股，成交量10.2461万股，换手率0.17%，振幅5.05%。Ascendis Pharma A/S股票所在的生物技术行业中，整体涨幅为0.73%。Ascendis Pharma A/S公司简介：Ascendis Pharma AS是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217004931984c7397&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217004931984c7397&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0889565916.HKD","LU0109394709.USD","BK4585","LU0320765992.SGD","BK4139","ASND"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120371630","title":"异动解读 | 阿森迪斯制药创下亮眼财报业绩,获机构力挺盘中股价大涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=1120371630","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1120371630?lang=zh_cn&edition=full","pubTime":"2024-11-23 01:28","pubTimestamp":1732296501,"startTime":"0","endTime":"0","summary":"阿森迪斯制药昨日盘中大涨5.19%,引发市场广泛关注。作为一家生物科技公司,阿森迪斯制药凭借其独有的Transcon技术开发多款新药,产品线丰富,满足患者医疗需求。随着各款新药产品线的不断推出,公司将持续受益于收入与净利润的增长。本次财报与机构评级的利好作用下,投资者对该股长期增长动力更加乐观,因而推动股价大涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 阿森迪斯制药创下亮眼财报业绩,获机构力挺盘中股价大涨5.19%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ASND"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ascendispharma.com","stockEarnings":[{"period":"1week","weight":-0.0274},{"period":"1month","weight":0.0666},{"period":"3month","weight":0.1073},{"period":"6month","weight":0.0785},{"period":"1year","weight":0.5083},{"period":"ytd","weight":0.1905}],"compareEarnings":[{"period":"1week","weight":-0.0059},{"period":"1month","weight":0.0078},{"period":"3month","weight":0.035},{"period":"6month","weight":0.0721},{"period":"1year","weight":0.1647},{"period":"ytd","weight":0.0836}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Ascendis Pharma A/s成立于2006年9月21日。该公司是一家临床阶段的生物制药公司，该公司运用其TransCon技术开发具有最佳的长效药物疗法的管道以解决大市场显著未满足的医疗需求。该公司正在开发其先导候选产品，TransCon人生长激素或生长激素TransCon，每周一次给药治疗生长激素缺乏症以及其他疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.636364,"avgChangeRate":0.031281},{"month":2,"riseRate":0.583333,"avgChangeRate":0.050705},{"month":3,"riseRate":0.416667,"avgChangeRate":0.030446},{"month":4,"riseRate":0.416667,"avgChangeRate":-0.031037},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.005122},{"month":6,"riseRate":0.666667,"avgChangeRate":0.035016},{"month":7,"riseRate":0.583333,"avgChangeRate":-0.003711},{"month":8,"riseRate":0.727273,"avgChangeRate":0.084941},{"month":9,"riseRate":0.636364,"avgChangeRate":0.039794},{"month":10,"riseRate":0.454545,"avgChangeRate":-0.00981},{"month":11,"riseRate":0.818182,"avgChangeRate":0.047363},{"month":12,"riseRate":0.545455,"avgChangeRate":0.041981}],"exchange":"NASDAQ","name":"Ascendis Pharma A/S","nameEN":"Ascendis Pharma A/S"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Ascendis Pharma A/S(ASND)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Ascendis Pharma A/S(ASND)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Ascendis Pharma A/S,ASND,Ascendis Pharma A/S股票,Ascendis Pharma A/S股票老虎,Ascendis Pharma A/S股票老虎国际,Ascendis Pharma A/S行情,Ascendis Pharma A/S股票行情,Ascendis Pharma A/S股价,Ascendis Pharma A/S股市,Ascendis Pharma A/S股票价格,Ascendis Pharma A/S股票交易,Ascendis Pharma A/S股票购买,Ascendis Pharma A/S股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Ascendis Pharma A/S(ASND)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Ascendis Pharma A/S(ASND)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}